top of page
News, Events and Updates
Search
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73
Oct 1, 2019
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference
Sep 26, 2019
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Sep 25, 2019
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 18, 2019
Anavex Life Sciences Announces Preliminary Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73
Sep 15, 2019
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019
Sep 4, 2019
Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study
Sep 4, 2019
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Study Updates
Aug 6, 2019
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, 8/7/2019
Aug 1, 2019
Anavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board
Jul 30, 2019
Anavex Life Sciences Receives Positive Opinion for Orphan Designation from European Medicines Agency
Jul 29, 2019
18
19
20
21
22
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
